GlassScriptPhysician profile
Dalton Singletry Mclean
NPI 1316995400
$22,337.78
in general payments reported to CMS, 2019-2025
44 companies · $3,270 in 2025
The $3,270 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,763 · 2020: $1,473 · 2021: $2,647 · 2022: $4,072 · 2023: $3,838 · 2024: $4,275 · 2025: $3,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,195.31 |
| Education | $187.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,272.42 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Triclip |
| United Therapeutics Corporation | $1,851.67 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Novartis Pharmaceuticals Corporation | $1,737.75 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,727.14 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Cvrx, INC. | $1,502.10 | 2019-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $1,337.35 | 2019-2025 | Wainua, Farxiga, Lokelma |
| Amgen INC. | $1,242.59 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,215.07 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,082.80 | 2019-2025 | Jardiance |
| Abiomed | $1,060.59 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $986.55 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $958.74 | 2019-2025 | Onpattro, Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $838.42 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $583.91 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Impulse Dynamics (USA) INC. | $519.70 | 2022-2025 | Optimizer, Optimizer |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $418.84 | 2019-2025 | Camzyos, Eliquis |
| Livanova USA, INC. | $385.54 | 2020-2023 | Vns - Vitaria |
| Pfizer INC. | $354.77 | 2019-2025 | |
| Irhythm Technologies, INC. | $336.89 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $227.11 | 2024-2025 | |
| Vifor Pharma, INC. | $208.81 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $174.86 | 2023-2024 | Inpefa |
| Arbor Pharmaceuticals, INC. | $154.23 | 2019-2020 | |
| Zoll Circulation INC | $146.56 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Novo Nordisk INC | $145.07 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $144.79 | 2019 | |
| Bridgebio Pharma, INC. | $143.85 | 2025 | Attruby |
| Daiichi Sankyo INC. | $116.37 | 2019-2023 | Injectafer |
| Biotronik INC. | $69.12 | 2019-2020 | |
| Liquidia Technologies, INC. | $52.00 | 2025 | Yutrepia |
| Otsuka America Pharmaceutical, INC. | $41.71 | 2019 | |
| Kestra Medical Technology Services, INC. | $40.75 | 2025 | Assure Wcd |
| Endotronix, INC. | $37.58 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Cardiovascular Systems INC. | $29.14 | 2021 | |
| Celgene Corporation | $28.40 | 2024 | Camzyos |
| Gilead Sciences, INC. | $27.28 | 2019 | |
| Portola Pharmaceuticals, LLC | $23.34 | 2019 | |
| Edwards Lifesciences Corporation | $19.67 | 2024 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $19.04 | 2023 | |
| Medtronic, INC. | $17.09 | 2025 | Biomedicus |
| Sensible Medical Innovations INC | $16.51 | 2019 | |
| Akcea Therapeutics, INC. | $14.78 | 2020 | |
| Lilly USA, LLC | $13.94 | 2025 | Zepbound, Mounjaro |
| Teleflex LLC | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalton Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.